SUMMARY Pharmacological differences between canine and monkey basilar arteries were studied in vitro. The constrictor response of canine basilar artery to either norepinephrine or an a ( -adrenoceptor agonist phenylephrine was partly inhibited by an a 2 -adrenoceptor antagonist yohimbine but not by an a,-adrenoceptor antagonist prazosin. The contraction elicited by an » 2 -adrenoceptor agonist clonidine was inhibited by neither prazosin nor yohimbine. These results suggest that the receptors in canine basilar artery which mediate norepinephrine-induced contraction are different from classical a, or a 2 -adrenoceptors, although they more closely resemble the a 2 -rather than the a|-subtype. Using monkey basilar artery, phenylephrine produced the same amplitude of maximum contractile response as norepinephrine, though a much higher concentration of phenylephrine than norepinephrine was needed in order to elicit that maximum response. Clonidine did not elicit contractions. The contraction induced by norepinephrine was markedly suppressed by both prazosin and yohimbine in a noncompetitive fashion. The constrictor response of monkey basilar artery to norepinephrine, therefore, appears to be mediated by «,-like adrenoceptors. Comparison of ED50 values for thromboxane A2 revealed that the monkey basilar artery was more sensitive to thromboxane A2 than that of the canine. Prostaglandin F2a produced a larger maximum contraction in monkey basilar arteries than in canine basilar arteries, although the ED 50 values for monkey basilar arteries were larger than those for canine basilar arteries. The ED 50 values for serotonin in canine basilar arteries were a little less than those for monkey basilar arteries, although both arteries produced nearly identical maximum contractions.
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Stroke Vol 16, No 3, 1985 SPECIES DIFFERENCES in the constrictor responses of cerebral arteries to vasoactive agents are of contemporary interest with regard to the pathophysiology of the cerebral circulation. Hardebo, et al 1 reported that histamine was a strong vasoconstrictor in rabbit cerebral arteries but a prominent vasodilator in human cerebral arteries. Norepinephrine is reported to be a much more potent cerebral artery spasmogen in man than in experimental animals such as rats, rabbits or dogs, 1 2 and a potential vasodilator in pig cerebral arteries. 3 Postjunctional a-adrenoceptors have recently been subclassified into a,-and a,-type adrenoceptors, based on relative potencies of selective agonists and antagonists. 4 " 8 Experiments using such selective agonists and antagonists have suggested that the vasoconstrictor responses of feline middle cerebral artery 9 -l0 and canine basilar artery 2 " to exogenous norepinephrine are predominantly mediated by the a,-adrenoceptor subtype. However, the nature of a,-adrenoceptors in canine cerebral arteries still remains controversial since some discrepancy exists between the experimental results by Sakakibara et al" and those by Toda. 2 Sakakibara et al" have reported that an a 2 -agonist clonidine elicited a constrictor response similar to that induced by norepinephrine, and that the response to either clonidine or norepinephrine was competitively inhibited by an a 2 -antagonist yohimibine. On the other hand, Toda 2 has demonstrated that clonidine-induced constrictions in canine cerebral arteries were appreciably less than those induced by norepinephrine, and that the antagonism of norepinephrine-induced constrictions by yohimbine was noncompetitive in nature. In addition, Toda 2 has recently reported that norepinephrine-induced constrictions are predominantly mediated by a,-adrenoceptors in human and monkey cerebral arteries, suggesting species differences in the nature of cerebral arterial a-adrenoceptors. Those results merit further investigations.
Species differences in the constrictor responses of cerebral arteries to vasoactive agents may have to be considered when designing studies of the pharmacology and pathophysiology of the cerebral circulation. In general, nonhuman primates are considered to be the best experimental animals because of anatomical, physiological and pathological relevance. However, only a limited amount of pharmacological information is available on the vascular reactivity of monkey cerebral arteries in vitro. " 14 The present comparative study was undertaken to evaluate the in vitro constrictor responses of monkey and canine cerebral arteries to several vasoactive agents. For correlative purposes, the nature of a-adrenoceptors in canine mesenteric artery was also studied.
Material and Methods
Adult mongrel dogs and cynomolgus monkeys (macaca fascicularis) of either sex were anesthetized with sodium pentobarbital (30 mg/kg) and sacrificed by exsanguination from the femoral artery. The basilar arteries from both species and the canine mesenteric artery were rapidly removed. The arteries were isolated under magnification and placed immediately in oxygenated, modified Kreb's bicarbonate solution t(mM):NaCl, 120; KC1, 4.5; MgSO 4 10 .0] at 37°C gassed with 95% O, and 5% CO 2 . The pH of the solution ranged from 7.40 to 7.50. Each artery was cut into 4 mm long ring segments which were suspended between L-shaped stainless steel holders in organ baths with a 10 ml working volume. Resting tension was adjusted to 1.5 g for monkey and canine basilar arteries and 2.0 g for canine mesenteric arteries. The preparations were allowed to equilibrate at 37°C for 60 minutes before use. Dose-response curves for norepinephrine, phenylephrine, clonidine, serotonin, prostaglandin F2a and thromboxane A2 (TXA2) were obtained by cumulative addition of the agonists. The synthetic TXA2 (9,11 -epithio-11,12-methano-TXA2) was used as a substitute for natural TXA2 in this experiment. Contractile force was recorded isometrically using a Grass FT.03 force-displacement transducer. The transducer signal was then amplified and displayed on a Gould 260 multichannel recorder. The contractile response to 40 mM KG was first obtained on each ring segment, then the preparations were repeatedly washed. The contractions induced by 40 mM KG were taken as 100%. Contractile activities of norepinephrine, phenylephrine, clonidine, serotonin, prostaglandin F2a and TXA2 were expressed as a percentage of the contraction elicited by a standard dose of 40 mM KG. Mean absolute values of the contractions induced by 40 mM KG in canine mesenteric and basilar arteries and in monkey basilar arteries were 9.12 ± 0.36 grams (mean ± S.E., N = 42), 6.28 ± 0.23 grams (N = 56) and 3.84 ± 0.25 grams (N = 47), respectively. The dry weights of 4 mm long ring segments of canine mesenteric and basilar and monkey basilar arteries were about 0.78 mg, 0.38 mg and 0.30 mg, respectively. In studies examining the inhibitory effects of prazosin and yohimbine on the contraction induced by norepinephrine, phenylephrine, or clonidine, preparations were exposed to those antagonists for 15 minutes before addition of agonists. The effects of /3-adrenoceptors and the effects of neuronal and extraneuronal uptake of catecholamines on the constrictor responses of monkey cerebral arteries to norepinephrine were examined by exposing the preparations for 15 minutes to 10~6 M propranolol, 10" 5 M cocaine or 10~5 M normetanephrine, respectively. In preliminary experiments using canine mesenteric arteries, it was confirmed that treatment of the specimens for 15 minutes with 10 6 M propranoiol, iO 5 M cocaine or 10~5 M normetanephrine augmented the constrictor responses to 10~6 M norepinephrine by about 9.4% (n = 6), 322% (n = 9), 70% (n = 8), respectively.
Statistical analysis of the dose response curves was done using split-plot analysis of variance (ANOVA), and a Scheffe test was used for subgroup analysis.
Comparison of each constrictor response with a matched control at a specific antagonist concentration and at each specific agonist concentration was made using a paired t-test. When p was smaller than 0.01, values were considered to be significantly different. For graphic presentation, the control values were averaged together. The pA 2 values for antagonists were calculated according to the method of Arunlakshana and Schild. 15 Computation of dose-response curves and ED 50 values was done using probit analysis with the SAS (Statistical Analysis System) computer program.
Drugs and solutions used in this study were ( ± ) -arterenol hydrochloride (Sigma Chemical Co.), 1-phenylephrine hydrochloride (Sigma Chemical Co.), clonidine hydrochloride (Boehringer Ingelheim Ltd.), yohimbine hydrochloride (Sigma Chemical Co.), prazosin hydrochloride (Pfizer Ltd.), dl-propranolol hydrochloride (Sigma Chemical Co.), cocaine hydrochloride (Mallinckrodt Co.) normetanephrine hydrochloride (Sigma Chemical Co.), 5-hydroxytryptamine (Sigma Chemical Co.), prostaglandin F2a (Sigma Chemical Co.), 9,11-epithio-11,12-methano-thromboxane A2 (Ono Pharmaceutical Co., Ltd.) and ethyleneglycol-bis (/3-aminoethylether)-N,N'-tetraacetic acid (Sigma Chemical Co.).
Norepinephrine was dissolved using a 50 mM phosphate buffer solution (pH 7.4) which contained 0.1% ascorbate. Prazosin and yohimbine were dissolved in a diluted thanol solution resulting in a final concentration of ethanol in the 10 ml organ bath of 0.001%. Preliminary experiments demonstrated that, at the concentrations used in the present work, this solvent did not affect the contractile responses to norepinephrine, phenylephrine or clonidine. TXA2 was dissolved in 1/15 M phosphate buffer (pH 7.4) to make a stock solution (3 X 10" 5 M) and diluted with distilled water before use. All other drugs were dissolved in saline.
Results

The Non-receptor Mediated Responses of Cerebral Arteries
In either canine or monkey basilar arteries exposed for 20 minutes to Ca ++ -free medium containing 0.5 mM EGTA and depolarized with 80 mM K G , the addition of Ca + + (0.5, 1,5, 10 mM) elicited dosedependent contractions ( fig. 1 ). These non-receptor mediated responses were quantitatively the same in both arterial beds.
The Constrictor Responses to a-adrenoceptor Agonists Canine Mesenteric Artery
The dose-response curves to a-adrenoceptor agonists are shown in figure 2 (right). Norepinephrine in concentrations ranging from 10"' M to 3 x 10" 5 M caused a dose-dependent increase in tension of mesenteric arterial strips. Phenylephrine evoked responses that were similar to, though slightly less in amplitude than, those obtained with norepinephrine. The ED 50 (95% confidence interval) for norepinephrine and phenylephrine were 2.47 (1.89-3.25) x 10" 6 M and 3.56(2.80-4.51) x 10~6M, respectively. In contrast, the vasoconstrictor response induced by clonidine was markedly less than that induced by norepinephrine or phenylephrine.
The dose-response curve of norepinephrine-induced contraction to the right. The maximum response to norepinephrine was not reduced by either prazosin or yohimbine. PA 2 values for prazosin and yohimbine were 7.62 ± 0.03 (mean ± SEM) and 6.82 ± 0.05, respectively. As shown in figure 3 (right), both prazosin and yohimbine also caused a parallel shift to the right of the phenylephrine dose-response curve. The PA, value for prazosin (7.71 ± 0.08) was higher than that for yohimbine (7.00 ± 0.02).
Canine Cerebral Artery
Cumulative dose-response relationships for the aadrenoceptor agonists are shown in figure 2 (left). The constrictor response of canine cerebral artery to either norepinephrine or phenylephrine was small when compared to that of the mesenteric artery. The constrictor response of canine basilar artery to phenylephrine was less than that to norepinephrine, except at the concentration of 1O~4 M phenylephrine. Clonidine at high concentrations (10~3 M and 3 x l0~3 M) produced stronger contractions than norepinephrine, while the constrictor response to lower concentrations (1O~6 M to 10" 4 M) of clonidine was less than that to norepinephrine.
The effects of a-adrenoceptor antagonists on norepinephrine-induced contraction are illustrated in fig- 
Neither prazosin (10~6 M and 10~5 M) nor yohimbine (10~6 M and 10" 5 M) showed any effect on clonidine-induced contractions in canine basilar artery (n = 8).
Monkey Cerebral Artery
Norepinephrine produced dose-related contractions of monkey basilar artery at appreciably lower concentrations (10~8 M to 3 x 10" 6 M) than in canine basilar artery. Further increases in the concentration of norepinephrine to 10~5 M and 3 x 10~5 M elicited relaxation ( fig. 6) . Treatment of the preparations with 10~6 M propranolol did not augment the constrictor responses to norepinephrine (n = 7). Application of phenylephrine in concentrations ranging from 10~7 M to 3 x 10~4 M to the basilar artery also caused doserelated contractions. The amplitude of the maximum response to phenylephrine was almost the same as that to norepinephrine, though a much higher concentration of phenylephrine than norepinephrine was needed in order to elicit that maximum response. The ED 50 (95% confidence interval) of norepinephrine and phenylephrine were 1.00(0.7-1.6) x 10' 7 M and 4.71 (2.33-9.19) x 10" 6 M, respectively. In contrast, clonidine at concentrations of 10~6, 10" 5 and 10~4 M failed to produce contraction, producing weak relaxation, instead.
The vasoconstrictor response to norepinephrine was markedly suppressed by both prazosin (10~6 M) (AN-OVA and Scheffe test, p < 0.001) and yohimbine (lO" 6 M) (ANOVA and Scheffe test, p < 0.001), and there was no statistical difference in the degree of antagonism between the two ( fig. 7) . The maximum contractile response was also inhibited by either antagonist.
Neither 10~5 M cocaine or 10~5 M normetanephrine altered the constrictor responses of monkey basilar arteries to norepinephrine at all norepinephrine concentrations tested (10~8 M to 3 x 10" 5 M) (n = 4).
The Constrictor Responses to TXA2, Prostaglandin F2a or Serotonin The dose-response curves for monkey basilar arteries were significantly different from canine basilar arteries for TXA2 (ANOVA, F = 103.35, p < 0.0001), prostaglandin F2a (ANOVA, F = 24.34, p < 0.0001), and serotonin (ANOVA. F = 38.30, p < 0.0001).
As shown in table 1, the mean value for TXA2 ED 50 in monkey basilar arteries was significantly less than that for canine basilar arteries while the maximum responses were the same in both arterial beds.
Prostaglandin F2a produced a larger maximum contraction in monkey basilar arteries than in canine basilar arteries, although the mean value for the ED 50 in monkey basilar arteries was larger than that for canine basilar arteries. The mean value for serotonin ED 50 in monkey basilar arteries was larger than that for canine basilar arteries while both arteries produced nearly identical maximum contractions.
Discussion
The present study has demonstrated the different reactivities of basilar arteries to norepinephrine, TXA2, prostaglandin F2a or serotonin between monkeys and dogs.
Norepinephrine produced strong dose-related contraction of canine mesenteric artery in concentrations ranging from 10" 7 M to 3 x 10~5 M. The relative potency of the a,-adrenoceptor agonist phenylephrine was equivalent to that of norepinephrine, while the a 2 -adrenoceptor agonist clonidine failed to produce such strong contractions. Antagonism experiments revealed that the constrictor response to either norepinephrine or phenylephrine was competitively inhibited by the a,-adrenoceptor antagonist prazosin. Although the a 2 -adrenoceptor antagonist yohimbine also inhibited the response to either norepinephrine or phenylephrine, pA 2 values for yohimbine were lower than those for prazosin. The pA, values observed were comparable to those reported previously 5 -6 l6 in tissues said to contain mainly a,-adrenoceptors. These results indicate that canine mesenteric artery contains mainly postjunctional a,-adrenoceptors as demonstrated by other investigators. 4 -
-" The constrictor response of isolated canine basilar artery to norepinephrine was extremely small when compared to that of mesenteric artery of a similar size. This finding is in agreement with the observations of other investigators. 17 " 20 The low sensitivity of canine cerebral artery to norepinephrine has previously been suggested to be independent of increased norepinephrine inactivation by amine uptake and catechol Omethyltransferase or masking by a /3-adrenergic mechanism, since responsiveness was not augmented by treatment with cocaine, normetanephrine, pyrogallol or propranolol.
19 2I Were the constrictor responses of canine cerebral artery to norepinephrine mediated through the receptor excitation process, sparse distribution of the receptors in canine cerebral artery would be one possible cause for the relative unresponsiveness. Recently, the atypical nature of a-adrenoceptors in canine cerebral artery has been suggested by experimental results which indicate that the constrictor response induced by either exogenous norepinephrine or transmural electrical stimulation is resistant to phentolamine and phenoxybenzamine. 18 " 20 An atypical nature is further supported by our experiment which revealed that the constrictor response of canine basilar artery to norepinephrine is not inhibited by the a,-adrenoceptor antagonist prazosin while it was partly suppressed by the a 2 -adrenoceptor antagonist yohimbine. These findings indicate that the a-adrenoceptors in canine basilar artery are similar to the a r subtype rather than the a r subtype. Should canine basilar artery contain predominantly a 2 -adrenoceptors, a,-adrenoceptor agonists would be expected to elicit a similar constrictor response to that induced by norepinephrine, while a 2 -adrenoceptor antagonists would inhibit the constrictor response. In this experiment, however, the vasoconstrictor response induced by the a,-adrenoceptor agonist clonidine was quite different from that induced by norepinephrine, and it was not inhibited by either the as-adrenoceptor antagonist yohimbine or the a,-adrenoceptor antagonist prazosin. Therefore, it is likely that clonidine-induced constriction is not mediated by either a 2 or (2,-adrenoceptors but rather by another mechanism. These findings suggest that the receptors in canine basilar artery which mediate norepinephrineinduced contraction are somewhat different from the a 2 -subtype, although further studies using more selective a,-adrenoceptor agonists and antagonists will be needed in order to better clarify the nature of a-adrenoceptor subtype in canine basilar arteries. Recently, it has been reported that the opioid antagonist naloxone selectively inhibited the constrictor response of canine basilar artery to norepinephrine while it failed to alter the response to phenylephrine or clonidine. 22 These results also confirm the atypical nature of receptors which mediate the constrictor response of canine basilar artery to norepinephrine.
This experiment further revealed that the constrictor response of canine basilar artery to phenylephrine was markedly inhibited by yohimbine while it was somewhat resistant to prazosin. Similar effectiveness of yohimbine on phenylephrine-induced constriction of canine cerebral arteries has been observed by Toda. 2 This unusual observation may indicate that the affinity of agonists and/or antagonists for a-adrenoceptors differ between canine cerebral and mesenteric artery. This unconventional observation merits further investigation.
The vasoconstrictor response of monkey basilar artery to a-adrenoceptor agonists was substantial using either norepinephrine or phenylephrine, although a much higher concentration of phenylephrine than norepinephrine was needed in order to elicit the same magnitude of contraction. Clonidine failed to produce contraction, producing weak relaxation instead. Antagonism experiments demonstrated that the constrictor response to norepinephrine was inhibited by either prazosin or yohimbine in a noncompetitive fashion. These findings suggest that the constrictor response of monkey basilar artery to norepinephrine is mediated by a,-like adrenoceptors, although the noncompetitive antagonism by prazosin or yohimbine is quite unlike the response of canine mesenteric artery to those drugs. Our experimental results are almost consistent with the findings by Toda.
2 With respect to the antagonism by yohimbine, however, some discrepancy exists between the results by Toda 2 and those of our experiments. Toda 2 reported that yohimbine did not affect the contractile responses of monkey cerebral arteries. On the other hand, the responses were noncompetitively attenuated by yohimbine in our experiments. The reason for this discrepancy is not apparent to the authors. Further studies will be needed in order to resolve this apparent conflict.
The present results further revealed that cocaine or normetanephrine at a concentration of l0~5 M, which was sufficient to potentiate the norepinephrine-induced constriction of canine mesenteric artery, did not influence the constrictor responses of monkey basilar arteries to exogenous norepinephrine. Similar observations have been reported in canine cerebral arteries.' 9 With respect to the inactivation of catecholamines by neuronal and extraneuronal uptake, therefore, no difference exists between monkey and canine cerebral arteries.
Comparison of the mean value for TXA2 ED 50 revealed that monkey cerebral artery was more sensitive to TXA2 than that of the canine, although the maximum contractions were not significantly different. When compared to present results, the effective concentrations of TXA2 in human cerebral arteries appear to be closer to those of the monkey than those of the canine.
The constrictor responses of basilar arteries to prostaglandin F2a and serotonin were also different between monkeys and dogs. Prostaglandin F2a produced a large maximum contraction in monkey basilar arteries than in canine basilar arteries, although the mean value for ED 50 in monkey basilar arteries was larger than that for canine basilar arteries. Monkey basilar arteries were a little less sensitive to serotonin than canine basilar arteries.
Such species differences may have to be considered when investigating the pharmacology and pathophysiology of cerebral circulation. Heistad, et al 24 have suggested that there are species differences in cerebral vascular responses to neural stimuli in vivo. Sympathetic stimulation in primates reduces cerebral blood flow while no significant reduction is observed in dogs or cats. Such differences may relate to the different nature of cerebral arterial a-adrenoceptors among species. With respect to the etiology of cerebral vasospasm following subarachnoid hemorrhage, norepinephrine has been thought unlikely to play an important role because of the ineffectiveness of sympathectomy or an a-adrenergic blocking agent, phentolamine, in the treatment of vasospasm, 25 the low concentration of norepinephrine in cerebrospinal fluid 26 and the low sensitivity of cerebral arteries to norepinephrine in experimental animals such as dogs 17 l9 - 27 or rabbits. 28 However, such a conclusion might be unjustified since primate cerebral arteries are highly sensitive to norepinephrine.'-2 29~3134 Further studies will be needed in order to clarify the role of norepinephrine in the etiology of cerebral vasospasm. The possible role of TXA2 in the pathogenesis of cerebral vasospasm has been suggested in a canine subarachnoid hemorrhage model. 32 33 The fact that the primate cerebral artery is more sensitive than the canine to TXA2, 14 34 may further support a possible role for TXA2 in human vasospasm.
In summary, the present study has demonstrated differences in the constrictor responses of cerebral arteries to norepinephrine, TXA2, prostaglandin F2a and serotonin between monkeys and dogs.
